“…Today, the detection systems based on sensory methods are applied to identify resistance to isoniazid (Ckumdee et al, 2017), rifampin (Miodek et al, 2015;Rachkov et al, 2013;Zribi et al, 2016), pyrazinamide (Rueda et al, 2018), and first-and second-line drugs, including anti-TB antibiotics (e.g., isoniazid, rifampin, ethambutol Genomic DNA of M. tb 20 mer: 5′-CTC GTC CAG CGC CGC TTC GG-3′ (Mohamad et al, 2017) Genomic DNA of M. tb 20 mer: 5′-CTC GTC CAG CGC CGC TTC GG-3′ (Ng et al, 2015) Not mentioned in the reference 20 mer: 5′-CTC GTC CAG CGC CGC TTC GG-3′ (Issa et al, 2010) IS6110 sequence 10 mer: 5′-GGTGAGGTCT-3′ (C. Liu et al, 2014) Not mentioned in the reference 21 mer: 5′-GGTCTTCGTGGCCGGCGTTCA-3′ (Mogha et al, 2018) Not mentioned in the reference 21 mer: 5′-IAC III CAA TCC AII IC-3′ (Nurmalasari et al, 2015) rpoB gene 15 mer: 5′-GATACTTCTATCACC-3′ (Miodek et al, 2015) Not mentioned in the reference 21 mer: 5′-GGT CTT CGT GGC CGG CGT TCA-3′ (Torati et al, 2016) Not mentioned in the reference 15 mer: 5′--GATACTTCTATCACC-3′ (Zribi et al, 2016) MPT64 antigen 77 bp aptamer: 5′-[Btn]GTACAAACGACGGCCAGTCCTTGGGATGATTCAAGCAAAG CCTCACGCCTACGGCTAAGTCATAGCTGTCTCTCCTG-3′ IFN-γ 37 bp aptamer: 5′-GGGGTTGGTTGTGTTGGGTGTTGTGTCCAACCCCCCC-3′ (Y. Liu et al, 2010) Genomic DNA of M. tb 25 mer: 5′-biotin GACCAAATAGGTATCGGCGTGTTCA-3′ (Yesil et al, 2016) Not mentioned in the reference 21 mer: 5′-GGT CTT CGT GGC CGG CGT TCA-3′ (Prabhakar et al, 2010) Genomic DNA of M. tb 24 mer: 5′-CGG TGG CGT GTT CTT TGT GCA ATA-3′ (Hsu et al, 2013) rpoB gene 21 mer: 5′-ACCCACAAGCGCCGACTGTTG-3′ (Rachkov et al, 2013) Genomic DNA of M. tb 22 mer: 5′-CCAACTTTGTTGTCATGCACCC-3′ (Duman & Piskin, 2010) Genomic region of ESAT-6 antigen Probe 1: 5′-NH2 [CH2]6-GTAAGTAAGGGAGGAAC-3′Probe2: 5′-TGCTCCCCT TCGTCAGG-[CH2]6-SH-3′ (Shojaei et al, 2014) IS6110 sequence 15 mer: 5′-ATCCGGCCACAGCCC-3′ (Kaewphinit et al, 2013) IS6110 sequence 5′-SH-[CH2] 6 -TTTTTTGTGGCCATCGTGGAAGCGA-3′ (Kaewphinit et al, 2010) hydrochloride, streptomycin, capreomycin, p-amino salicylic acid, rifabutin, and ethionamide; Ren et al, 2013), in the hopes that these systems continue to improve.…”